Home › Glioma › Washington › Seattle
Studi clinici su Glioma a Seattle, WA
11 studi su Glioma cercano partecipanti presso sedi a Seattle e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
In reclutamentoFase 1/2
- Seattle Children's Hospital, Seattle
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
In reclutamentoFase 2
- Seattle Children's Hospital, Seattle
Targeted Pediatric High-Grade Glioma Therapy
In reclutamentoStudio osservazionale
- Seattle Children's Hospital, Seattle
Study of Olutasidenib and Temozolomide in HGG
In reclutamentoFase 2
- Seattle Children's Hospital, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
In reclutamentoFase 3
- Fred Hutch Cancer Center, Seattle
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
In reclutamentoFase 2
- Seattle Children's Hospital, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
In reclutamentoFase 2
- University of Washington School of Medicine, Seattle
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
In reclutamentoFase 1 inizialeVolontari sani benvenuti
- Seattle Children's Hospital, Seattle
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
In reclutamentoFase 2
- Seattle Children's Hospital, Seattle
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
In reclutamentoFase 1
- Seattle Children's Hospital, Seattle
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
In reclutamentoFase 1 iniziale
- Seattle Children's Hospital, Seattle
Studi su Glioma in altre città
- New York City, NY25 studi
- Houston, TX23 studi
- Boston, MA20 studi
- Washington, DC19 studi
- Philadelphia, PA16 studi
- Miami, FL15 studi
- Columbus, OH15 studi
- San Francisco, CA14 studi
- Chicago, IL13 studi
- Durham, NC12 studi
- Los Angeles, CA10 studi
- St. Louis, MO10 studi
Altri studi a Seattle
- Cancro del polmone non a piccole cellule53 studi
- Cancro (tutti i tipi)49 studi
- Cancro alla prostata42 studi
- Leucemia mieloide acuta40 studi
- Cancro al seno39 studi
- Cancro metastatico39 studi
- Cancro colorettale34 studi
- Cancro ai polmoni33 studi
- Cancro ovarico30 studi
- Mieloma multiplo22 studi
- Sindromi mielodisplastiche21 studi
- Leucemia linfoblastica acuta21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.